Tianjin Tianyao Pharmaceutical Co (SHSE:600488) EPS (Basic): ¥0.03 (TTM As of Mar. 2026)


SHSE:600488 Tianjin Tianyao Pharmaceutical Co Ltd SHSE:600488
64 GF Score
Price ¥4.69
GF Value ¥3.60
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Tianjin Tianyao Pharmaceutical Co EPS (Basic)?

Tianjin Tianyao Pharmaceutical Co SHSE:600488 -5.82% 64 EPS (Basic) is ¥0.03 as of Mar. 2026. GuruFocus rates SHSE:600488 with a GF Score™ of 64/100 and a GF Value™ of ¥3.60 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Tianjin Tianyao Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ¥0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥0.03.

Tianjin Tianyao Pharmaceutical Co's EPS (Diluted) for the three months ended in Mar. 2026 was ¥0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥0.03.

Tianjin Tianyao Pharmaceutical Co's EPS without NRI for the three months ended in Mar. 2026 was ¥0.03. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 0.10.

During the past 12 months, Tianjin Tianyao Pharmaceutical Co's average EPS without NRIGrowth Rate was -43.50% per year. During the past 3 years, the average EPS without NRI Growth Rate was 14.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was 32.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 4.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Tianjin Tianyao Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 54.30% per year. The lowest was -37.50% per year. And the median was 7.30% per year.

Tianjin Tianyao Pharmaceutical Co  (SHSE:600488) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Tianjin Tianyao Pharmaceutical Co EPS (Basic) Related Terms

Tianjin Tianyao Pharmaceutical Co EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Tianjin Tianyao Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tianjin Tianyao Pharmaceutical Co EPS (Basic) Chart

Tianjin Tianyao Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.03 0.11 0.12 0.07

Tianjin Tianyao Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 -0.01 0.02 0.00 0.01
SHSE:600488
64GF Score
Tianjin Tianyao Pharmaceutical Co Ltd SHSE:600488
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tianjin Tianyao Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Tianjin Tianyao Pharmaceutical Co's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(70.564-0)/1085.606
=0.06

Tianjin Tianyao Pharmaceutical Co's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(13.891-0)/1068.562
=0.01

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ¥0.03 mean?
Tianjin Tianyao Pharmaceutical Co (SHSE:600488) has a EPS (Basic) of ¥0.03 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Tianjin Tianyao Pharmaceutical Co and its competitors.
Is Tianjin Tianyao Pharmaceutical Co's EPS (Basic) too high?
Tianjin Tianyao Pharmaceutical Co's current EPS (Basic) is ¥0.03. Overall, Tianjin Tianyao Pharmaceutical Co has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tianjin Tianyao Pharmaceutical Co's EPS (Basic) compare to ZTS?
Tianjin Tianyao Pharmaceutical Co's EPS (Basic) of ¥0.03 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Tianjin Tianyao Pharmaceutical Co and its competitors. Tianjin Tianyao Pharmaceutical Co's current EPS (Basic) is ¥0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tianjin Tianyao Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Tianjin Tianyao Pharmaceutical Co (SHSE:600488) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥3.60, compared to a current price of ¥4.69 — trading 30.3% above its estimated fair value. The current EPS (Basic) is ¥0.03. Tianjin Tianyao Pharmaceutical Co's overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Tianjin Tianyao Pharmaceutical Co (SHSE:600488), the current EPS (Basic) is ¥0.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tianjin Tianyao Pharmaceutical Co (SHSE:600488) Overvalued in 2026?

Based on GuruFocus' analysis, Tianjin Tianyao Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥4.69 is trading 30.3% above its estimated GF Value™ of ¥3.60. GuruFocus considers Tianjin Tianyao Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for SHSE:600488:

  • EPS (Basic): ¥0.03
  • GF Value™: ¥3.60 vs. price of ¥4.69 (30.3% above fair value)
  • GF Score™: 64/100 with 6 warning signs

No single metric tells the full story. See the SHSE:600488 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tianjin Tianyao Pharmaceutical Co Business Description

Address No. 221 Huanghai Road, Tianjin Development Zone, Tianjin, CHN, 300457
Tianjin Tianyao Pharmaceutical Co Ltd is a China-based company engages in the development, manufacture, distribution, and export of pharmaceutical products. Its products include corticosteroids and cardiovascular medicine, dexamethasone, and cortisone acetate.
64GF Score

Get the complete analysis for SHSE:600488

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.69
Price
¥3.60
GF Value